Redeye trims fair value for Medcap after Q3 margin beat
Redeye published analyst research on Medcap’s Q3 2026 margin beat and trimmed its fair value estimate.
Related stories
Vale Q3 Iron Ore Production Falls 6%
Vale said third-quarter iron ore production fell 6%.
M impact | EQUITY | Oct 29, 2026, 11:53 PM UTC
Frontera Energy Announces Third-Quarter 2026 Results Conference Call
M impact | EQUITY | Oct 29, 2026, 11:51 PM UTC
Frontera Energy Announces Third-Quarter 2026 Results Call
M impact | EQUITY | Oct 29, 2026, 11:51 PM UTC
Intel Shares Plunge 21% After Hours on Israel Plant Blast and Weak PC Market
Intel shares fell 21% in after-hours trading following a fatal explosion at its Israel plant and weakness in the PC market, according to Reuters.
M impact | EQUITY | Oct 29, 2026, 11:51 PM UTC
Japan manufacturers see November output up 0.8% month over month
L impact | EQUITY | Oct 29, 2026, 11:51 PM UTC
Zillow to Pay Shareholders $212.5 Million in Legal Settlement
Zillow has agreed to pay investors $212.5 million in a legal settlement nearly five years after shutting its home-flipping business.
M impact | EQUITY | Oct 29, 2026, 11:50 PM UTC